节点文献

氟他胺治疗前列腺癌的Ⅱ期临床观察

PHASE I CLINICAL TRIAL OF FLUTAMIDE IN THE TREATMENT OF PROSTATIC CARCINOMA

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 赵体平姚育梅张永康黄翼然氟他胺临床协作小组姚笃卿严伟民闻小英沈慷

【Author】 ZHAO Ti-ping YAOYu-mei ZHANG Yong-kang HUANG Yi-ran(Flutamide clinical trial group 200032) YAO Du-qing YAN Wei-ming WEN Xiao-ying SHEN Kang(Hongqi Pharmaceutical Factory, Shanghai Medical University 200032)

【机构】 上海医科大学肿瘤医院上海医科大学中山医院上海第二医科大学仁济医院上海医科大学红旗制药厂上海医科大学红旗制药厂 200032200032200001200032

【摘要】 氟他胺是非甾体类雄激素拮抗剂,用于治疗前列腺癌100例,采用美国生产缓退瘤(Fugerel)治疗前列腺癌31例作为对照组。结果氟他胺组有效率86%,缓退瘤组有效率87.09%,两组无显著差异,均无明显不良反应,结果表明氟他胺是一种治疗前列腺癌较满意药物。

【Abstract】 Flutamide is a nonsteroidal antiandrogen and is used to treat prostatic cancer. This study compared Flutamide tablet and Fugerel (Schering Plough Carp, USA) in the treatment of Prostatic cancer (100 cases for Flutamide V. S. 31 cases for Fugerel). The statistical analysis revealed no significant difference with respect to response rates (Flutamide 86% , Fugerel 87. 09% respectivelly)and no obvious adverse reaction was found. These data indicate that Flutamide is an effective and save agent in the management of patients with pro-static cancer.

  • 【文献出处】 临床药学 ,Chinese Journal of Clinical Pharmacy , 编辑部邮箱 ,1995年02期
  • 【分类号】R737.25
  • 【下载频次】52
节点文献中: 

本文链接的文献网络图示:

本文的引文网络